MISSISSAUGA, Ontario, Oct. 2 /PRNewswire-FirstCall/ -- JAG Media Holdings, Inc. (OTC Bulletin Board: JAGH) filed with the Secretary of State of Nevada yesterday a certificate of amendment to its Articles of Incorporation, which changed the Company's name to CardioGenics Holdings Inc., to better reflect its new business direction following its acquisition of CardioGenics Inc., and increased the Company's authorized common shares from 500,000,000 to 650,000,000.
The Company has submitted to FINRA all documentation requested in connection with the Company's name change, and the related changes of the Company's ticker symbol and CUSIP number for the Company's common shares. Until such changes are implemented by FINRA, the Company's common shares will continue to trade under its current symbol, JAGH.
About CardioGenics Holdings Inc.
Through its CardioGenics subsidiaries, the Company develops technology and products targeting the immunoassay segment of the In-Vitro Diagnostic testing market. It has developed the QL Care Analyzer, a proprietary Point Of Care immuno-analyzer, which will run a number of diagnostic tests under development, the first of which will be a series of cardiovascular diagnostic tests. As part of its core proprietary technology, the Company has also developed a proprietary method for silver coating paramagnetic microspheres (a fundamental platform component of immunoassay equipment), which improve instrument sensitivity to light. The Company's principal offices are located in Mississauga, Ontario, Canada.
Safe Harbor Statement - Certain statements made herein that are not historical are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995 and may contain forward-looking statements, with words such as "Anticipate, "believe," "expect," "future," "may," "will," "should," "plan," "projected," "int
|SOURCE JAG Media Holdings, Inc.|
Copyright©2009 PR Newswire.
All rights reserved